Literature DB >> 9445411

Papillary and follicular thyroid carcinoma.

M J Schlumberger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9445411     DOI： 10.1056/NEJM199801293380506

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  293 in total

Review 1.  Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects.

Authors:  N J Sarlis
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

Review 2.  The management of metastatic differentiated thyroid carcinoma.

Authors:  S I Sherman
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

3.  Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21.

Authors:  J D McKay; F Lesueur; L Jonard; A Pastore; J Williamson; L Hoffman; J Burgess; A Duffield; M Papotti; M Stark; H Sobol; B Maes; A Murat; H Kääriäinen; M Bertholon-Grégoire; M Zini; M A Rossing; M E Toubert; F Bonichon; M Cavarec; A M Bernard; A Boneu; F Leprat; O Haas; C Lasset; M Schlumberger; F Canzian; D E Goldgar; G Romeo
Journal:  Am J Hum Genet       Date:  2001-07-02       Impact factor: 11.025

4.  Managing differentiated thyroid cancer.

Authors:  Pat Kendall-Taylor
Journal:  BMJ       Date:  2002-04-27

5.  A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis.

Authors:  Muneki Hotomi; Iwao Sugitani; Kazuhisa Toda; Kazuyoshi Kawabata; Yoshihide Fujimoto
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

6.  Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer.

Authors:  J D McKay; D Thompson; F Lesueur; K Stankov; A Pastore; C Watfah; S Strolz; G Riccabona; R Moncayo; G Romeo; D E Goldgar
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

7.  Proliferative activity in pregnancy-related thyroid papillary carcinoma.

Authors:  María Genoud; Julio Oliva; Graciela Fernández Alonso; Marcelo Nallar; H Rubén Harach
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

8.  Indium-111 octreotide scintigraphy for the detection of non-functioning metastases from differentiated thyroid cancer: diagnostic and prognostic value.

Authors:  Marcel P M Stokkel; Robbert B Verkooijen; Jan W A Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-26       Impact factor: 9.236

9.  BRAF mutation correlates with recurrent papillary thyroid carcinoma in Chinese patients.

Authors:  F J Huang; W Y Fang; L Ye; X F Zhang; L Y Shen; R L Han; Q Wei; X C Fei; X Chen; W Q Wang; S Wang; G Ning
Journal:  Curr Oncol       Date:  2014-12       Impact factor: 3.677

Review 10.  Lessons from mouse models of thyroid cancer.

Authors:  Caroline S Kim; Xuguang Zhu
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.